iodine-131 monoclonal antibody BC8
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for iodine-131 monoclonal antibody BC8, covering 2017-10-12 to 2023-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome [Phase 1]